mouse antibodies against stat1 α (1:500) Search Results


mouse mab sx118  (Becton Dickinson)
90
Becton Dickinson mouse mab sx118
(A) Treating PC3-AR cells with si PARP7 partially reduces the growth inhibitory effect of RBN2397. PARP7 knockdown in the cell growth experiments (A-C) was confirmed by immunoblotting using TUBULIN as a loading control (upper panels). For the cell growth in A-C, each RBN2397 concentration reflects eight biological replicates, error bars show the standard deviation, and the statistical differences between cell lines at each RBN concentration are ****, p<0.0001; ***, p<0.001; **, <0.01; *, <0.05 (lower panels). (B, C) Stable knockdown of PARP7 in PC3-AR and CWR22Rv1 cells partially protects from the growth inhibitory effects of RBN2397. CWR22Rv1( shGFP ) cell growth is copied from . (D) Immunoblot detection of CDK inhibitor <t>p21</t> and PARP7 in prostate cancer lines grown +R1881 and +RBN2397 for 24 hrs. (E) Treating PC3-AR cells with si-p21 (20 nM) partially reverses the growth inhibitory effect of RBN2397. The expression levels of p21 and PARP7 +R1881 and +RBN2397 were determined by immunoblotting (upper panel). (F) CRISPR knockout of CDKN1A (p21) in PC3-AR cells reduces the growth inhibitory effect of RBN2397. The knockout was confirmed by DNA sequencing (not shown) and by immunoblotting for p21 (upper panel).
Mouse Mab Sx118, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+antibodies+against+stat1+%CE%B1+%281%3A500%29/bio_rxiv__2022__09__02__506406-197-23-29?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
mouse mab sx118 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
rat anti-cd62l  (Becton Dickinson)
90
Becton Dickinson rat anti-cd62l
(A) Treating PC3-AR cells with si PARP7 partially reduces the growth inhibitory effect of RBN2397. PARP7 knockdown in the cell growth experiments (A-C) was confirmed by immunoblotting using TUBULIN as a loading control (upper panels). For the cell growth in A-C, each RBN2397 concentration reflects eight biological replicates, error bars show the standard deviation, and the statistical differences between cell lines at each RBN concentration are ****, p<0.0001; ***, p<0.001; **, <0.01; *, <0.05 (lower panels). (B, C) Stable knockdown of PARP7 in PC3-AR and CWR22Rv1 cells partially protects from the growth inhibitory effects of RBN2397. CWR22Rv1( shGFP ) cell growth is copied from . (D) Immunoblot detection of CDK inhibitor <t>p21</t> and PARP7 in prostate cancer lines grown +R1881 and +RBN2397 for 24 hrs. (E) Treating PC3-AR cells with si-p21 (20 nM) partially reverses the growth inhibitory effect of RBN2397. The expression levels of p21 and PARP7 +R1881 and +RBN2397 were determined by immunoblotting (upper panel). (F) CRISPR knockout of CDKN1A (p21) in PC3-AR cells reduces the growth inhibitory effect of RBN2397. The knockout was confirmed by DNA sequencing (not shown) and by immunoblotting for p21 (upper panel).
Rat Anti Cd62l, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+antibodies+against+stat1+%CE%B1+%281%3A500%29/10__1038_slash_s43587___021___00049___z-216-132-138?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
rat anti-cd62l - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
p stat1 tyr701  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc p stat1 tyr701
(A) Treating PC3-AR cells with si PARP7 partially reduces the growth inhibitory effect of RBN2397. PARP7 knockdown in the cell growth experiments (A-C) was confirmed by immunoblotting using TUBULIN as a loading control (upper panels). For the cell growth in A-C, each RBN2397 concentration reflects eight biological replicates, error bars show the standard deviation, and the statistical differences between cell lines at each RBN concentration are ****, p<0.0001; ***, p<0.001; **, <0.01; *, <0.05 (lower panels). (B, C) Stable knockdown of PARP7 in PC3-AR and CWR22Rv1 cells partially protects from the growth inhibitory effects of RBN2397. CWR22Rv1( shGFP ) cell growth is copied from . (D) Immunoblot detection of CDK inhibitor <t>p21</t> and PARP7 in prostate cancer lines grown +R1881 and +RBN2397 for 24 hrs. (E) Treating PC3-AR cells with si-p21 (20 nM) partially reverses the growth inhibitory effect of RBN2397. The expression levels of p21 and PARP7 +R1881 and +RBN2397 were determined by immunoblotting (upper panel). (F) CRISPR knockout of CDKN1A (p21) in PC3-AR cells reduces the growth inhibitory effect of RBN2397. The knockout was confirmed by DNA sequencing (not shown) and by immunoblotting for p21 (upper panel).
P Stat1 Tyr701, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+antibodies+against+stat1+%CE%B1+%281%3A500%29/bio_rxiv__2022__09__02__506406-197-67-69?v=Cell+Signaling+Technology+Inc
Average 96 stars, based on 1 article reviews
p stat1 tyr701 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier
anti mouse igg  (Rockland Immunochemicals)
96
Rockland Immunochemicals anti mouse igg
(A) Treating PC3-AR cells with si PARP7 partially reduces the growth inhibitory effect of RBN2397. PARP7 knockdown in the cell growth experiments (A-C) was confirmed by immunoblotting using TUBULIN as a loading control (upper panels). For the cell growth in A-C, each RBN2397 concentration reflects eight biological replicates, error bars show the standard deviation, and the statistical differences between cell lines at each RBN concentration are ****, p<0.0001; ***, p<0.001; **, <0.01; *, <0.05 (lower panels). (B, C) Stable knockdown of PARP7 in PC3-AR and CWR22Rv1 cells partially protects from the growth inhibitory effects of RBN2397. CWR22Rv1( shGFP ) cell growth is copied from . (D) Immunoblot detection of CDK inhibitor <t>p21</t> and PARP7 in prostate cancer lines grown +R1881 and +RBN2397 for 24 hrs. (E) Treating PC3-AR cells with si-p21 (20 nM) partially reverses the growth inhibitory effect of RBN2397. The expression levels of p21 and PARP7 +R1881 and +RBN2397 were determined by immunoblotting (upper panel). (F) CRISPR knockout of CDKN1A (p21) in PC3-AR cells reduces the growth inhibitory effect of RBN2397. The knockout was confirmed by DNA sequencing (not shown) and by immunoblotting for p21 (upper panel).
Anti Mouse Igg, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+antibodies+against+stat1+%CE%B1+%281%3A500%29/10__1158_slash_2767___9764__crc___23___0086-100-96-100?v=Rockland+Immunochemicals
Average 96 stars, based on 1 article reviews
anti mouse igg - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier
p stat1  (Cell Signaling Technology Inc)
95
Cell Signaling Technology Inc p stat1
(A) Treating PC3-AR cells with si PARP7 partially reduces the growth inhibitory effect of RBN2397. PARP7 knockdown in the cell growth experiments (A-C) was confirmed by immunoblotting using TUBULIN as a loading control (upper panels). For the cell growth in A-C, each RBN2397 concentration reflects eight biological replicates, error bars show the standard deviation, and the statistical differences between cell lines at each RBN concentration are ****, p<0.0001; ***, p<0.001; **, <0.01; *, <0.05 (lower panels). (B, C) Stable knockdown of PARP7 in PC3-AR and CWR22Rv1 cells partially protects from the growth inhibitory effects of RBN2397. CWR22Rv1( shGFP ) cell growth is copied from . (D) Immunoblot detection of CDK inhibitor <t>p21</t> and PARP7 in prostate cancer lines grown +R1881 and +RBN2397 for 24 hrs. (E) Treating PC3-AR cells with si-p21 (20 nM) partially reverses the growth inhibitory effect of RBN2397. The expression levels of p21 and PARP7 +R1881 and +RBN2397 were determined by immunoblotting (upper panel). (F) CRISPR knockout of CDKN1A (p21) in PC3-AR cells reduces the growth inhibitory effect of RBN2397. The knockout was confirmed by DNA sequencing (not shown) and by immunoblotting for p21 (upper panel).
P Stat1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+antibodies+against+stat1+%CE%B1+%281%3A500%29/10__1158_slash_2767___9764__crc___23___0086-100-67-70?v=Cell+Signaling+Technology+Inc
Average 95 stars, based on 1 article reviews
p stat1 - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

Image Search Results


(A) Treating PC3-AR cells with si PARP7 partially reduces the growth inhibitory effect of RBN2397. PARP7 knockdown in the cell growth experiments (A-C) was confirmed by immunoblotting using TUBULIN as a loading control (upper panels). For the cell growth in A-C, each RBN2397 concentration reflects eight biological replicates, error bars show the standard deviation, and the statistical differences between cell lines at each RBN concentration are ****, p<0.0001; ***, p<0.001; **, <0.01; *, <0.05 (lower panels). (B, C) Stable knockdown of PARP7 in PC3-AR and CWR22Rv1 cells partially protects from the growth inhibitory effects of RBN2397. CWR22Rv1( shGFP ) cell growth is copied from . (D) Immunoblot detection of CDK inhibitor p21 and PARP7 in prostate cancer lines grown +R1881 and +RBN2397 for 24 hrs. (E) Treating PC3-AR cells with si-p21 (20 nM) partially reverses the growth inhibitory effect of RBN2397. The expression levels of p21 and PARP7 +R1881 and +RBN2397 were determined by immunoblotting (upper panel). (F) CRISPR knockout of CDKN1A (p21) in PC3-AR cells reduces the growth inhibitory effect of RBN2397. The knockout was confirmed by DNA sequencing (not shown) and by immunoblotting for p21 (upper panel).

Journal: bioRxiv

Article Title: Induction of PARP7 Creates a Vulnerability for Growth Inhibition by RBN2397 in Prostate Cancer Cells

doi: 10.1101/2022.09.02.506406

Figure Lengend Snippet: (A) Treating PC3-AR cells with si PARP7 partially reduces the growth inhibitory effect of RBN2397. PARP7 knockdown in the cell growth experiments (A-C) was confirmed by immunoblotting using TUBULIN as a loading control (upper panels). For the cell growth in A-C, each RBN2397 concentration reflects eight biological replicates, error bars show the standard deviation, and the statistical differences between cell lines at each RBN concentration are ****, p<0.0001; ***, p<0.001; **, <0.01; *, <0.05 (lower panels). (B, C) Stable knockdown of PARP7 in PC3-AR and CWR22Rv1 cells partially protects from the growth inhibitory effects of RBN2397. CWR22Rv1( shGFP ) cell growth is copied from . (D) Immunoblot detection of CDK inhibitor p21 and PARP7 in prostate cancer lines grown +R1881 and +RBN2397 for 24 hrs. (E) Treating PC3-AR cells with si-p21 (20 nM) partially reverses the growth inhibitory effect of RBN2397. The expression levels of p21 and PARP7 +R1881 and +RBN2397 were determined by immunoblotting (upper panel). (F) CRISPR knockout of CDKN1A (p21) in PC3-AR cells reduces the growth inhibitory effect of RBN2397. The knockout was confirmed by DNA sequencing (not shown) and by immunoblotting for p21 (upper panel).

Article Snippet: Commercial antibodies used were TUBULIN (1:10,000–20,000, mouse mAb TUB-1A2, Sigma T9028), HA tag (1:1,000, mouse mAb 16b12, Covance A488-101L, also used for IP), p21 (1 μg/ml, mouse mAb SX118, BD Pharmingen 550827), AHR (1 μg/ml, Rabbit mAb JM34-10, Thermo Fisher Scientific MA5-32576), CYCLIN B1 (1:10,000, rabbit mAb Y106, Epitomics 1495-1), CYCLIN A (1:500, mouse mAb 6E6, Leica Microsystems NCL-CYCLIN A), STAT1α (1:1,000, rabbit mAb EPR4407, abcam ab109320), p-STAT1(Tyr701)(1:1,000, rabbit, Cell Signaling 9171), LAMIN A/C (1:40, mouse mAb JOL2, Millipore MAB3211), Alexa Fluor 680 donkey anti-Rabbit IgG(H + L) (1:20,000, Invitrogen A10043), IRDye800-conjugated anti-mouse IgG(H&L) (1:20,000, Rockland 610-132-121), and AR (mouse mAb G122-434, BD Pharmingen 554225, used for IP).

Techniques: Western Blot, Concentration Assay, Standard Deviation, Expressing, CRISPR, Knock-Out, DNA Sequencing